These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 21933428

  • 1. Early reduction in painful physical symptoms is associated with improvements in long-term depression outcomes in patients treated with duloxetine.
    Schneider E, Linden M, Weigmann H, Wagner T, Quail D, Hundemer HP, Hegerl U.
    BMC Psychiatry; 2011 Sep 20; 11():150. PubMed ID: 21933428
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Switching to duloxetine in selective serotonin reuptake inhibitor non- and partial-responders: effects on painful physical symptoms of depression.
    Perahia DG, Quail D, Desaiah D, Montejo AL, Schatzberg AF.
    J Psychiatr Res; 2009 Feb 20; 43(5):512-8. PubMed ID: 18707693
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study.
    Gaynor PJ, Gopal M, Zheng W, Martinez JM, Robinson MJ, Hann D, Marangell LB.
    Curr Med Res Opin; 2011 Oct 20; 27(10):1859-67. PubMed ID: 21838410
    [Abstract] [Full Text] [Related]

  • 8. Time course of improvement of different symptom clusters in patients with major depression and pain treated with duloxetine or placebo.
    Demyttenaere K, Desaiah D, Petit C, Croenlein J, Brecht S.
    Curr Med Res Opin; 2012 Jan 20; 28(1):41-8. PubMed ID: 22126422
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Early vs. conventional switching of antidepressants in patients with MDD and moderate to severe pain: a double-blind randomized study.
    Romera I, Pérez V, Menchón JM, Schacht A, Papen R, Neuhauser D, Abbar M, Picard H, Gilaberte I.
    J Affect Disord; 2012 Dec 20; 143(1-3):47-55. PubMed ID: 22858211
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A randomised controlled trial comparing duloxetine and acetyl L-carnitine in fibromyalgic patients: preliminary data.
    Leombruni P, Miniotti M, Colonna F, Sica C, Castelli L, Bruzzone M, Parisi S, Fusaro E, Sarzi-Puttini P, Atzeni F, Torta RG.
    Clin Exp Rheumatol; 2015 Dec 20; 33(1 Suppl 88):S82-5. PubMed ID: 25786048
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evidence for the efficacy of duloxetine in treating mild, moderate, and severe depression.
    Shelton RC, Andorn AC, Mallinckrodt CH, Wohlreich MM, Raskin J, Watkin JG, Detke MJ.
    Int Clin Psychopharmacol; 2007 Nov 20; 22(6):348-55. PubMed ID: 17917553
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Real-world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia.
    Hong J, Novick D, Montgomery W, Moneta MV, Dueñas H, Peng X, Haro JM.
    Asia Pac Psychiatry; 2016 Mar 20; 8(1):51-9. PubMed ID: 25808275
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.